Navigation Links
Anthera Pharmaceuticals Reports 2013 Second Quarter Financial Results
Date:7/30/2013

HAYWARD, Calif., July 30, 2013 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and business highlights for the quarter ended June 30, 2013.

Second Quarter 2013 Financial Results: Loss from operations decreased in the second quarter of 2013 to $7.0 million from $16.7 million in the second quarter of 2012, and to $13.9 million for the six months ended June 30, 2013 compared to $36.7 million for the comparable period in 2012.  The decreases in loss from operations primarily resulted from a decrease in research and development expenses due to the Company's shift in focus to the development of blisibimod for systemic lupus erythematosus, or lupus, and IgA nephropathy, an orphan disease in the United States.  

Net loss for the quarter ended June 30, 2013 was $8.3 million, or $0.43 loss per basic and diluted share, compared with a net loss of $17.6 million, or $3.43 loss per basic and diluted share for the quarter ended June 30, 2012. Net loss in the current quarter included a non-cash charge of $0.5 million in unamortized note discount and debt issuance cost as a result of the Company's successful restructuring of its debt obligations with Hercules Technology Growth Capital. The Company reported a net loss of $15.9 million or $0.92 per basic and diluted share for the six months ended June 30, 2013, compared with a net loss of $38.5 million or $7.51 per basic and diluted share for the comparable period in 2012. The decrease in net losses per basic and diluted share in 2013 as compared to 2012 both quarterly and year-to-date were primarily due to the result of lower loss from operations, and higher common shares outstanding attributable to the closing of an underwritten public offering of 8,712,119 shares of the Company's common stock in January 2013 from which the Co
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Anthera Announces Initiation of BRIGHT-SC Phase 2 Clinical Study in IgA Nephropathy with Blisibimod
2. Anthera Pharmaceuticals Announces Receipt of Nasdaq Notice
3. Anthera Pharmaceuticals Announces Personnel Changes
4. Anthera Pharmaceuticals to Present at Annual Jefferies Healthcare Conference
5. Anthera Pharmaceuticals Reports 2013 First Quarter Financial Results
6. Anthera Pharmaceuticals Announces Additional Data from Phase 2b PEARL-SC Blisibimod Study
7. Anthera Refinances Existing Debt with New $20 Million Credit Facility and Secures $18.5 Million Committed Equity Financing Facility
8. Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod
9. Anthera Announces Data from the Phase 2b PEARL-SC Study Will Be Presented at the 10th International Congress on Systemic Lupus Erythematosus
10. Anthera Pharmaceuticals to Present at the 2013 Leerink Global Healthcare Conference
11. Anthera Pharmaceuticals Announces Departure of Georgina Kilfoil
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... -- Talyst, a market leader in pharmacy automation and ... Summer Conference in Las Vegas, NV. ... products and services.   Talyst is the ... customers with a variety of software and services. Talyst ... solution, AutoSplit® Contract Pharmacy and 340B Compliance Services. AutoSplit ...
(Date:8/19/2014)... , Aug. 19, 2014  As power morcellator ... country, Bernstein Liebhard LLP notes that women in ... between a number of options that do not ... instrument. According to a report published by The ... these options include a mini-laparotomy and vaginal hysterectomy. ...
(Date:8/19/2014)... RIDGEFIELD, Conn. , Aug. 19, 2014 /PRNewswire/ ... and Drug Administration (FDA) accepted for review the ... (FDC) of tiotropium and olodaterol delivered via the ... of long-term, once-daily maintenance treatment of airflow obstruction ... including chronic bronchitis and/or emphysema. Tiotropium + olodaterol ...
Breaking Medicine Technology:Talyst Exhibits at the NPPA Summer Conference 2As Morcellator Lawsuits Mount, Bernstein Liebhard LLP Notes Report Detailing Alternatives to Uterine Morcellation 2As Morcellator Lawsuits Mount, Bernstein Liebhard LLP Notes Report Detailing Alternatives to Uterine Morcellation 3Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 2Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 3Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 4Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 5Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 6Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 7Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 8
... , NEW YORK, Dec. 2 Reportlinker.com ... in its catalogue: , Cardiovascular Devices: Technologies ... , Offer a comprehensive view of the cardiovascular devices ... of the major types of cardiovascular diagnostic equipment, including ...
... , ... new market research report is available in its catalogue: ... Trends , http://www.reportlinker.com/p0164212/Chiral-Technology---International-Technology--Market-Trends.html , The ... a flurry of activity with pharmaceutical companies adding chiral ...
Cached Medicine Technology:Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 2Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 3Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 4Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 5Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 6Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 7Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 8Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 9Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 10Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 11Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 12Reportlinker Adds Chiral Technology - International Technology & Market Trends 2Reportlinker Adds Chiral Technology - International Technology & Market Trends 3Reportlinker Adds Chiral Technology - International Technology & Market Trends 4Reportlinker Adds Chiral Technology - International Technology & Market Trends 5
(Date:8/20/2014)... 2014 GBK, the luxury lifestyle gift lounge ... Nominees and Presenters at the annual GBK Gift Lounge. This ... in Beverly Hills from 11am – 6pm. GBK will offer ... DJ Morgan Hildebrand. , As always, GBK will blend this ... charities at the lounge. GO Campaign is a grantmaking organization ...
(Date:8/20/2014)... Riverside Health System is pleased to announce ... Warsaw Medical Arts team earlier this year, bringing the ... accepting new patients. , Dameron, a 2009 graduate of ... at the Mountain Area Health Education Center in Asheville, ... like the rural aspect of [Tappahannock],” Dameron said of ...
(Date:8/19/2014)... 20, 2014 BambooIndustry.com, a well-known bamboo product ... bamboo deckings recently. The company is excited to reveal ... summer special offer for all clients. Now, every customer can ... promotion will last until August 30. , The company’s ... in the world for supreme durability. They are perfect for ...
(Date:8/19/2014)... Top 10 Best SEO Hosting (Top10BestSEOHosting.com) has released its ... today and included in the list is Arvixe. , ... most outstanding suppliers on the list, beating out a number ... 10 Best SEO Hosting, Arvixe provides easy to use products ... Arvixe prides itself in providing web hosting with a rare ...
(Date:8/19/2014)... LunaDress, a popular supplier of fashionable ... ladies, is now providing a discount of up to ... company’s cheap white prom outfits are available in different ... outfits. , There are over 400 cheap white ... the special offer is valid until August 29, 2014. ...
Breaking Medicine News(10 mins):Health News:GBK Presents a Luxury Gift Lounge Honoring the Nominees and Presenters of the 2014 Emmy® Awards - August 22nd and 23rd - Beverly Hills 2Health News:GBK Presents a Luxury Gift Lounge Honoring the Nominees and Presenters of the 2014 Emmy® Awards - August 22nd and 23rd - Beverly Hills 3Health News:GBK Presents a Luxury Gift Lounge Honoring the Nominees and Presenters of the 2014 Emmy® Awards - August 22nd and 23rd - Beverly Hills 4Health News:Riverside Warsaw Medical Arts’ Dr. William Dameron Accepting New Patients 2Health News:Promotional Bamboo Deckings from Well-known Online Supplier BambooIndustry.com 2Health News:Top 10 Best SEO Hosting: Best Web Hosting Suppliers For 2014 Awarded to Arvixe 2Health News:Popular Supplier LunaDress Providing an Exclusive Assortment of White Prom Dresses at a Discount of Up to 67% 2
... BOSTON (April 13, 2011) In the first study ... ulcerative stomatitis (CUS), researchers at Tufts University School of ... to the painful oral sores that characterize the disease. ... a new autoimmune disease. Chronic ulcerative stomatitis is ...
... NYU Langone Medical Center have identified three novel small ... regulates many aspects of development and cancer. The finding, ... Proceedings of the National Academy of Sciences ... for innovative therapies for colorectal cancer and other diseases ...
... News) -- Men who are victims of domestic abuse ... as post-traumatic stress disorder (PTSD), depression and suicidal thoughts, ... of 302 men who sought professional help after experiencing ... to high levels of violence and controlling behavior by ...
... News) -- Consuming omega-3 fatty acids in fish oil capsules ... according to a new study. Researchers looked at 52 ... oil capsule containing 300 milligrams of docosahexaenoic acid (DHA) five ... of pregnancy. DHA is a prominent omega-3 fatty acid. ...
... -- When children who were blind from birth were able ... to make the connection between what they were seeing and ... reveals. However, they gained that ability within a few ... a natural ability to make a connection between different types ...
... 2011 Elsevier, a world leader in health care ... significant expansion of scientific content to be published in ... of the American Brachytherapy Society (ABS). Published both ... from a quarterly to bimonthly publication schedule in 2011. ...
Cached Medicine News:Health News:New evidence that chronic ulcerative stomatitis is an autoimmune disease 2Health News:Small molecules inhibit growth of human tumor cells 2Health News:Small molecules inhibit growth of human tumor cells 3Health News:Male Victims of Domestic Abuse May Show Signs of PTSD 2Health News:Fish Oil Promising Against Postpartum Depression in Small Trial 2Health News:Brachytherapy, the official journal of ABS, expands to 6 issues in 2011 2
... ACULAR® ophthalmic solution is a prescription ... instruct you to use after your ... eyes and may cause them to ... symptoms of inflammation include redness and ...
... solution is a prescription eye drop ... to use after your cataract surgery. ... may cause them to become inflamed. ... inflammation include redness and swelling. If ...
... ECG-9320 is a full-featured ECG ... IEC60601-2-51 new international standard for ... digital filter performance. The ECG ... managed on a Windows PC ...
Mid-level interpretive resting ECG...
Medicine Products: